Ruth Frampton
- Pathology and Forensic Medicine top 5%
- Molecular Biology
- Genetics
- Oncology
- Endocrinology, Diabetes and Metabolism
- Co-authors
- T. John MartinV. P. MichelangeliDavid M. FindlayJohn A. EismanI. MacIntyreJane M. MoseleyT. R. BradleyNicola C. Partridge
- Topics
- Vitamin D Research Studies (5 papers)Diabetes Treatment and Management (4 papers)Diabetes Management and Research (4 papers)
- Partner nations
- Australia
In The Last Decade
Ruth Frampton
14 papers receiving 505 citations
Peers
Comparison fields: 5 of 69
- Pathology and Forensic Medicine 239
- Molecular Biology 217
- Genetics 170
- Oncology 154
- Endocrinology, Diabetes and Metabolism 90
Countries citing papers authored by Ruth Frampton
This map shows the geographic impact of Ruth Frampton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Frampton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Frampton more than expected).
Fields of papers citing papers by Ruth Frampton
This network shows the impact of papers produced by Ruth Frampton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Frampton. The network helps show where Ruth Frampton may publish in the future.
Co-authorship network of co-authors of Ruth Frampton
This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Frampton. A scholar is included among the top collaborators of Ruth Frampton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Frampton. Ruth Frampton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 3 | |
| 6 | 33 | |
| 7 | 5 | |
| 8 | 6 | |
| 9 | 1 | |
| 10 | 21 | |
| 11 | 2 | |
| 12 | Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture. | 115 |
| 13 | Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines. | 103 |
| 14 | 147 | |
| 15 | 53 | |
| 16 | 52 |
About Ruth Frampton
Ruth Frampton is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Cell Biology, having authored 16 papers that have together received 548 indexed citations. Recurring topics across this work include Vitamin D Research Studies (5 papers), Diabetes Treatment and Management (4 papers) and Diabetes Management and Research (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (239 citations), Genetics (170 citations) and Oncology (154 citations). Ruth Frampton has collaborated with scholars based in Australia. Frequent co-authors include T. John Martin, V. P. Michelangeli, David M. Findlay, John A. Eisman, John A. Eisman, T. John Martin, I. MacIntyre, Jane M. Moseley, T. R. Bradley and Nicola C. Partridge. Their work appears in journals such as Diabetes Care, Biochemical and Biophysical Research Communications and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.